MedTrace Logo

Correlation Between Cardiac Markers and Severity of COVID-19

NCT05040750 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 207

Last updated 2024-10-08

No results posted yet for this study

Summary

By July 9, 2020, the global pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection had resulted in over 11.8 million confirmed cases and over 545000 deaths. Patients with a history of cardiovascular disease are especially vulnerable and have a bad prognosis. According to the findings, cardiac injury manifested by cardiac biomarker elevation is detected in a significant number of COVID-19 patients and is linked to poor outcomes and mortality. However, it is unclear how effective cardiac biomarkers are in COVID-19 prognosis and how to use these indicators.

Conditions

  • Cardiac Event

Interventions

OTHER

laboratory investigation

observe the relation between cardiac markers and mortality rate in critically ill COVID 19 patients

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Fathy Tash, MD · Ain Shams University

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-01
Primary Completion
2023-07-30
Completion
2023-07-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05040750 on ClinicalTrials.gov